Such an increase in autophagic markers, however, does not necessarily imply the stimulation of autophagy, as it may represent the accumulation of autophagic vesicles due to an inhibition of the autophagic flux. Although Grotemeier et al. still observe a thapsigargin-mediated increase in LC3-II in Jurkat T cells, despite inhibition of the autophagic flux with lysosomal inhibitors, 16 other experiments using lysosomal inhibitors indicate that thapsigargin and Ca 2C ionophores rather inhibit the autophagic flux than stimulate autophagy, 17, 18 thus thereby reducing the degradation of long-lived proteins. 19, 20 This has both been linked to an effect of thapsigargin on autophagosome-lysosome fusion, 18 as well as to an impaired biogenesis of autophagosomes downstream of WIPI1-puncta formation. 20 Altogether, these results demonstrate that comparing autophagy in different conditions should be done with great care: treatment of the cells with either thapsigargin or ionophores leads to nonphysiological elevations in Ca 2C with amplitudes and spatio-temporal characteristics that are different from Ca 2C signals triggered by physiological agonists. Moreover, the nature and consequences of these Ca 2C signals are dependent on the applied concentrations of those Ca 2C mobilizers and the duration of the treatment. Finally, a similar Ca 2C -dependent inhibitory effect on autophagosome formation is proposed to occur downstream of the plasma membrane Ltype Ca 2C channels. 17 Antagonists of the latter appear to induce autophagy by a mechanism involving cyclic adenosine monophosphate-dependent regulation of the IP 3 levels and calpain activation. Hence, inhibition of these Ca 2C signals by depleting cellular IP 3 levels with lithium chloride is proposed to activate autophagy and thereby to prevent protein aggregation in neurodegeneration. 11, 17 Different studies using pharmacological inhibitors or ITPR-knockdown approaches 6-10 also propose an inhibitory role for the ITPR and the IP 3 -induced Ca 2C release with respect to autophagy, albeit via different mechanisms. Kroemer and coworkers propose a Ca 2C -independent scaffolding role for ITPRs by enhancing the formation of the antiautophagic BCL2-BECN1/Beclin 1 complex. 7 Alternatively, Foskett and coworkers advocate the importance of ITPR-mediated Ca 2C oscillations that drive mitochondrial ATP production, thereby suppressing the activity of AMPK, 8 a positive regulator of autophagy. 21 As such, DT40 cells in which all 3 ITPR isoforms are genomically deleted display an increased AMPK activation and elevated basal autophagic flux. 8 Although these studies indicate that ITPRs are able to inhibit basal autophagy levels, other studies reveal the requirement of ITPR-mediated Ca 2C -release during starvation-, 13 rapamycin-, 14 or natural killer cell 22 -induced autophagy in mammalian cells and during differentiation factor-induced autophagy in Dictyostelium.
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The different outcomes and the proposed roles of the ITPR in autophagy are possibly due to a divergent role of the ITPRs with respect to basal vs. stress-induced autophagy. Indeed, our study shows that while ITPR inhibition by Xestospongin B stimulates the basal autophagic flux, it also abrogates the starvation-induced autophagic flux. 13 In line with the latter view, a recent report by Mikoshiba and coworkers, using the tandem red/green fluorescent protein reporter RFP-GFP-LC3 in HeLa cells reveals that knockdown of ITPR1 leads to an accumulation of autophagosomes. 23 Interestingly, the autophagosomes are not randomly located (as observed after treatment with bafilomycin A 1 ), but are restricted to the perinuclear space. Cells in which TGM2 (transglutaminase 2), an ITPR regulator, has been knocked down, show increased ITPR-mediated Ca 2C signaling and display mostly autolysosomes, similar to starvation-subjected cells, indicating enhanced autophagic clearance. 23 Although further independent confirmation will be needed, these first data support a concept in which ITPR-mediated Ca 2C release can enhance the trafficking of autophagosomes toward lysosomes, thereby promoting the autophagic flux. In any case, all these different reports strongly advocate the need for proper analysis of the autophagic flux when using Ca 2C mobilizers.
Another important aspect of the complex relation between Ca 2C signaling and autophagy, is the fact that the ER Ca 2C stores are remodeled during autophagy, and the functional properties of the ITPRs are modified by essential autophagy proteins. 13, 14, 24 These findings have implications for autophagy activity, because it has already been demonstrated that autophagy is dependent on the Ca 2C present in the intracellular Ca 2C stores rather than on the extracellular Ca 2C . 19 Nutrient starvation leads to an overall sensitization of Ca 2C -release events from the ER, by increasing the ER Ca 2C -store content and by promoting IP 3 -induced Ca 2C release. 13 The former is linked to an increased ER Ca 2C -buffering capacity due to an upregulation of ER lumenal Ca 2C -binding proteins concomitant with a decreased passive Ca 2C leak from the ER, whereas the latter is linked to a direct interaction of BECN1 with the ITPR, thereby sensitizing the channel toward lower IP 3 concentration. Due to their mechanism of action, the use of compounds such as thapsigargin or Ca 2C ionophores will eliminate the functional consequences of these fine-tuned alterations in ER Ca 2C and ITPR function that are critical to drive the autophagic flux. It is interesting to note that autophagy-deficient T cells lacking ATG7 (autophagy related 7) expand their ER Ca 2C stores and increase ER Ca 2C levels by upregulating ATP2A, which may serve as a compensatory mechanism in an attempt to restore autophagic flux. 24 Hence, there is clear evidence that Ca 2C and ITPRs are able to both stimulate and suppress autophagosome synthesis as well as to both enhance and inhibit the autophagic flux. ITPRs and Ca 2C can execute such opposing functions due to the different spatio-temporal characteristics of Ca 2C signals that can be generated, each having distinct impacts on different steps in the autophagy pathway (Fig. 1) release. Interestingly, activation of TPCNmediated Ca 2C -signaling inhibits autophagosome-lysosome fusion events by alkalinizing lysosomal pH through an unknown mechanism. 37 Underscoring the importance of lysosomal Ca 2C in autophagy, a very recent report demonstrates that nutrient starvation promotes Ca 2C release from the lysosomes through the Ca 2C channel MCOLN1/TRPML1 (mucolipin 1). 38 This Ca 2C results in the activation of the protein phosphatase PPP3/calcineurin (protein phosphatase 3) in a microdomain around the lysosomes, and the subsequent -release activity by promoting the interaction of BCL2 with BECN1 and thus preventing the formation of the active class III phosphatidylinositol 3-kinase (PtdIns3K) complex. ITPR-mediated Ca 2C release can also be enhanced by BECN1 and TMBIM6 and dampened by TGM2, thereby influencing omegasome formation (possibly through PtdIns3K activation) and autophagosome maturation/trafficking. ITPR-mediated Ca 2C release can also influence the lysosomal Ca 2C concentration and lysosomal Ca 2C release through TPCNs, likely influencing lysosomal fusion events, or through MCOLN1, influencing autophagic and lysosomal gene transcription through a pathway involving PPP3/calcineurin and TFEB. signaling not only affect autophagy, but reciprocally ITPRs and Ca 2C signaling are modulated by the autophagy process in general and by essential autophagy proteins in particular. Hence, considering the complex interrelation between ITPRs and Ca 2C signaling in autophagy, it can be questioned whether the direct pharmacological targeting of these Ca 2C -release channels holds potential as a future therapy in autophagy-dependent diseases. However, interesting possibilities lay within the fine-tuning of the Ca 2C -flux properties of the channels such as the ITPRs by affecting its dynamic regulation via associated proteins, as has been successfully done with respect to associated anti-apoptotic BCL2 proteins. 40, 41 For example, BECN1 is recruited by ITPRs during starvation-induced autophagy and sensitizes the ITPRs to low levels of IP 3 (Fig. 1) . 13 In contrast, TGM2, a protein that induces protein crosslinking, counteracts enhanced ITPR-mediated Ca 2C signaling during autophagy stimulation. 23 Modulating regulatory proteins acting on the ITPRs could thus fine-tune the ITPRmediated Ca 2C signals in cells undergoing autophagy, thereby enhancing or reducing the autophagic flux as appropriate. For example, an increase in covalent posttranslational modifications of ITPR1 mediated by TGM2, resulting in a dampened ITPR1 activity, is already found in animal Huntington disease models and in primary B lymphocytes obtained from Huntington patients. 23 Limiting TGM2 activity could in those conditions enhance the ITPR-mediated Ca 2C release, stimulate the autophagy pathway and thus increase the autophagy-mediated degradation of mutant HTT (huntingtin). The advantage of such an approach will be that it may not lead to general elevations in cytosolic Ca 2C concentration, which has been linked to autophagy inhibition and an impaired clearance of aggregate-prone proteins in neurodegenerative diseases. 17 In conclusion, identifying the molecular determinants underlying the formation of multiprotein complexes between the ITPRs and associated regulatory proteins may thus provide new therapeutic avenues to modulate autophagy in the context of human pathologies.
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